Source: Eur Respir Monogr 2012; 58: 95-110
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Keertan Dheda, Grant Theron, Jonathan G. Peter, Greg Symons, Rodney Dawson, Paul Willcox. TB drug resistance in high-incidence countries. Eur Respir Monogr 2012; 58: 95-110

Member's Comments

No comment yet.

Related content which might interest you: TB drug resistance in low-incidence countries Source: Eur Respir Mon 2012; 58: 111-123 Year: 2012 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 The burden of childhood and adult tuberculosis, including MDR and TDR TB Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Prevention of TB in areas of low incidence Source: Eur Respir Mon 2012; 58: 72-83 Year: 2012 Strategies against multidrug-resistant tuberculosis Source: Eur Respir J 2002; 20: 66S-77S Year: 2002 Recent transmission of drug resistant M. tuberculosis in Latvia Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017 Year: 2017 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006